Bevacizumab Injection and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Bevacizumab Injection and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Injection-Insulin glulisine
- Bevacizumab Injection-Insulin Glulisine (Cartridges and Pens)
- Bevacizumab Injection-Insulin Glulisine (Vials)
- Bevacizumab Injection-Insulin glulisine Subcutaneous
- Bevacizumab Injection-Insulin human inhaled Inhalation
- Bevacizumab Injection-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Bevacizumab Intravenous
- Insulin glargine, recombinant Subcutaneous-Bevacizumab-awwb
- Insulin glargine, recombinant Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin glargine, recombinant Subcutaneous-Bevespi Aerosphere
- Insulin glargine, recombinant Subcutaneous-Bevyxxa
- Insulin glargine, recombinant Subcutaneous-Bexarotene